Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1

Detalles Bibliográficos
Autores principales: Kohrt, Holbrook, Kowanetz, Marcin, Gettinger, Scott, Powderly, John, Koeppen, Hartmut, Sosman, Jeffrey A, Cruz, Cristina, Xiao, Yuanyuan, Mokatrin, Ahmad, Fine, Gregg, Chen, Daniel S, Hodi, F Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991257/
http://dx.doi.org/10.1186/2051-1426-1-S1-O12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991257/
http://dx.doi.org/10.1186/2051-1426-1-S1-O12

Ejemplares similares